Economic burden in patients with anaplastic lymphoma kinase (ALK)-positive non-small cell lung cancer (NSCLC), with or without brain metastases, receiving first-line ALK inhibitors

por Wu, Yanyu, Ren, Kaili, Wan, Yin, Lin, Huamao M
Publicado 2022

EGFR Testing Patterns and Detection of EGFR Exon 20 Insertions in the United States

por Lin, Huamao M., Yin, Yu, Crossland, Victoria, Wu, Yanyu, Ou, Sai-Hong Ignatius
Publicado 2022

Real-World Treatment Patterns, Outcomes, and Healthcare Resource Utilization in Relapsed or Refractory Multiple Myeloma: Evidence from a Medical Record Review in France

por Lin, Huamao Mark, Davis, Keith L., Kaye, James A., Luptakova, Katarina, Nagar, Saurabh P., Mohty, Mohamad
Publicado 2019

A Low Temperature Drifting Acoustic Wave Pressure Sensor with an Integrated Vacuum Cavity for Absolute Pressure Sensing

por Wang, Tao, Tang, Zhengjie, Lin, Huamao, Zhan, Kun, Wan, Jiang, Wu, Shihao, Gu, Yuandong, Luo, Wenbo, Zhang, Wanli
Publicado 2020

Humanistic burden of living with anaplastic lymphoma kinase-positive non-small-cell lung cancer: findings from the ALKConnect patient insight network and research platform

por Lin, Huamao M, Pan, Xiaoyun, Biller, Alyssa, J Covey, Kyla, Huang, Hui, Sugarman, Rebecca, Scipione, Fatima, West, Howard
Publicado 2020

Flexible thin-film acoustic wave devices with off-axis bending characteristics for multisensing applications

por Ji, Zhangbin, Zhou, Jian, Lin, Huamao, Wu, Jianhui, Zhang, Dinghong, Garner, Sean, Gu, Alex, Dong, Shurong, Fu, YongQing, Duan, Huigao
Publicado 2021

Identifying symptomatic adverse events using the patient‐reported outcomes version of the common terminology criteria for adverse events in patients with non‐small cell lung cancer...

por Zhu, Yanyan, Jean‐Baptiste, Milenka, Lenderking, William R., Bell, Jill A., Revicki, Dennis A., Lin, Huamao M., Brake, Rachael, Reeve, Bryce B.
Publicado 2022

Real-World Response and Outcomes in Patients With NSCLC With EGFR Exon 20 Insertion Mutations

por Ou, Sai-Hong Ignatius, Lin, Huamao M., Hong, Jin-Liern, Yin, Yu, Jin, Shu, Lin, Jianchang, Mehta, Minal, Nguyen, Danny, Neal, Joel W.
Publicado 2023

Real-World Efficacy and Tolerability of Brigatinib in Patients with Non-Small Cell Lung Cancer with Prior ALK-TKIs in the United States

por Jahanzeb, Mohammad, Lin, Huamao M, Wu, Yanyu, Zhang, Pingkuan, Gorritz, Magdaliz, McGuiness, Catherine B, Huang, Wei-Ti, Sun, Kainan, Chen, Chi-Chang, Camidge, D Ross
Publicado 2022

Mobocertinib (TAK-788) in EGFR Exon 20 Insertion+ Metastatic NSCLC: Patient-Reported Outcomes from EXCLAIM Extension Cohort

por Garcia Campelo, Maria Rosario, Zhou, Caicun, Ramalingam, Suresh S., Lin, Huamao M., Kim, Tae Min, Riely, Gregory J., Mekhail, Tarek, Nguyen, Danny, Goodman, Erin, Mehta, Minal, Popat, Sanjay, Jänne, Pasi A.
Publicado 2022

Treatment Outcomes and Safety of Mobocertinib in Platinum-Pretreated Patients With EGFR Exon 20 Insertion–Positive Metastatic Non–Small Cell Lung Cancer: A Phase 1/2 Open-label Non...

por Zhou, Caicun, Ramalingam, Suresh S., Kim, Tae Min, Kim, Sang-We, Yang, James Chih-Hsin, Riely, Gregory J., Mekhail, Tarek, Nguyen, Danny, Garcia Campelo, Maria R., Felip, Enriqueta, Vincent, Sylvie, Jin, Shu, Griffin, Celina, Bunn, Veronica, Lin, Jianchang, Lin, Huamao M., Mehta, Minal, Jänne, Pasi A.
Publicado 2021

Brigatinib Versus Crizotinib in Advanced ALK Inhibitor–Naive ALK-Positive Non–Small Cell Lung Cancer: Second Interim Analysis of the Phase III ALTA-1L Trial

por Camidge, D. Ross, Kim, Hye Ryun, Ahn, Myung-Ju, Yang, James C. H., Han, Ji-Youn, Hochmair, Maximilian J., Lee, Ki Hyeong, Delmonte, Angelo, García Campelo, Maria Rosario, Kim, Dong-Wan, Griesinger, Frank, Felip, Enriqueta, Califano, Raffaele, Spira, Alexander, Gettinger, Scott N., Tiseo, Marcello, Lin, Huamao M., Gupta, Neeraj, Hanley, Michael J., Ni, Quanhong, Zhang, Pingkuan, Popat, Sanjay
Publicado 2020